Journal Article

New strategy to attenuate pulse wave velocity in haemodialysis patients

Tsuneo Takenaka and Hiromichi Suzuki

in Nephrology Dialysis Transplantation

Published on behalf of European Renal Association - European Dialysis and Transplant Assoc

Volume 20, issue 4, pages 811-816
Published in print April 2005 | ISSN: 0931-0509
Published online April 2005 | e-ISSN: 1460-2385 | DOI:
New strategy to attenuate pulse wave velocity in haemodialysis patients

Show Summary Details


Background. Pulse wave velocity (PWV) is commonly elevated in haemodialysis (HD) patients having cardiovascular diseases. Disturbances in calcium–phosphate metabolism are among the established cardiovascular risk factors in HD patients. The present study was performed to assess the effect of sevelamer on PWV in HD patients.

Methods. Fifteen patients, who had been treated with calcium carbonate as a phosphate binder, were entered into the study. Changes in PWV during the 6 months before sevelamer administration were compared with PWV changes during 6 months of receiving sevelamer. Serum biochemistry parameters were also assessed.

Results. Compared with the preceding control period, the sevelamer period resulted in decreased serum calcium (9.9±0.1 to 9.6±0.1 mg/dl, n = 15; P<0.01) in association with reductions in oral calcium load (4.3±0.4 to 2.3±0.6 g/day; P<0.001). Serum phosphorus and whole parathyroid hormone remained unchanged. Sevelamer reduced serum total cholesterol (167±7 to 148±6 mg/dl; P<0.001) and LDL-cholesterol (85±8 to 65±7 mg/dl; P<0.001), without modifying HDL-cholesterol or triglycerides. Finally, sevelamer reversed the increase in PWV observed during the control period (from 46±16 to −20±9 cm/s/month; P<0.01).

Conclusions. In chronic HD patients, sevelamer decreased serum total- and LDL-cholesterol as well as calcium. Moreover, our findings suggest that treatment with sevelamer attenuates the progressive increase in PWV observed during calcium carbonate treatment.

Keywords: blood pressure; calcium overload; dyslipidaemia; hyperphosphataemia; parathyroid hormone

Journal Article.  2867 words.  Illustrated.

Subjects: Nephrology

Full text: subscription required

How to subscribe Recommend to my Librarian

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.